12 Grants
2022
The role of a lysosomal mechano-sensitive ion channel in pain
Fehrenbacher, Jill C and Sheets, Patrick L
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1R21NS130417-01), $435,875USD, 2022-09-28 -- 2024-08-31
 
The Role of Calcitonin Gene-Related Peptide in rapidly progressive osteoarthritis induced by anti-nerve growth factor
Fehrenbacher, Jill C
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R21AG073921-01A1), $237,750USD, 2022-06-01 -- 2024-03-31
2021
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA231267-04), $460,814USD, 2018-09-10 -- 2023-08-31
 
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA205166-05), $537,592USD, 2017-04-01 -- 2022-03-31
2020
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA231267-03), $460,814USD, 2018-09-10 -- 2023-08-31
 
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA205166-04), $537,592USD, 2017-04-01 -- 2022-03-31
2019
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA231267-02), $446,989USD, 09/10/2018 -- 08/31/2023
 
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA205166-03), $521,463USD, 04/01/2017 -- 03/31/2022
2018
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
Fehrenbacher, Jill C and Kelley, Mark R
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA231267-01), $460,814USD, 09/10/2018 -- 08/31/2023
2016
DNA damage and repair in inflammation-induced peripheral sensitization
Fehrenbacher, Jill C⋅Kelley, Mark R and VASKO, MICHAEL R
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5R21NS091667-02), $195,000USD, 02/01/2015 -- 01/31/2018
2010
THE ROLE FOR THE GPR30 RECEPTOR IN INFLAMMATORY PAIN
Fehrenbacher, Jill C
National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) (ID: 5R21DE018796-03), $154,000USD, 05/05/2009 -- 04/30/2012
2009
THE ROLE FOR THE GPR30 RECEPTOR IN INFLAMMATORY PAIN
Fehrenbacher, Jill C
National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR) (ID: 7R21DE018796-02), $269,500USD, 05/05/2009 -- 04/30/2011